Inizio Medical has announced the appointment of Matt Wadyka as president, US medical affairs. In this newly created role, Wadyka will collaborate across the business to architect solutions and drive growth and innovation within the US market.
With over two decades of experience in the medical communications industry, Wadyka has a wealth of knowledge and expertise. Most recently, he served as global head of scientific communications at Roche/Genentech, where he was responsible for evolving the company’s scientific communications strategy and ensuring its impact on patient care.
Elaine Ferguson, global president at Inizio Medical, said: “Matt’s relentlessness for excellence and understanding of the commercial requirements to succeed in this market coupled with his proven track record in driving innovation will be invaluable.”
Wadyka said: “I look forward to joining Inizio Medical and leveraging the various talents to bring value to the evolving needs of our pharma/biotech partners within the US. I hope my experience in driving organisational change can provide a new lens and bring new opportunities for existing and future clients.”